Global Cephalosporin Drugs Market - Trends, Market Analysis - 2017 - 2022

  • ID: 4388364
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 4
The Global Cephalosporin Drugs Market is estimated to be $ xx billion for the year 2015 to reach $ xx billion by the year 2020. The CAGR with which market is growing is anticipated to be x.x%.

The cephalosporins are a group of broad spectrum, semi-synthetic beta-lactam antibiotics derived from the group Cephalosporium. For few indications, cephalosporins are the preferred anti antibiotics. The key driver for the growth of this market is increasing research and development activities in many countries and the growing demand of anti-bacterials. The market is expected to experience uncertain regulatory reforms and spending high in research and development does not fetch the expected return of investment. It has also been observed that there is less drug development in pipeline for this category of anti-bacterials.

The global cephalosporin drugs market is segmented based on the spectrum of anti-microbial activity which includes first generation, second generation, third generation, fourth generation and fifth generation. The market is also segmented by the route of administration such as oral and injectables, by type such as branded and generics. The therapeutic segment of the market includes sexually transmitted infections, serious infections, respiratory tract infections, skin infections, urinary tract infections in pregnancy. The geographical regions considered include North America, Europe, Latin America, Middle East Asia and Asia Pacific. The clinical trial support services regulations differs from region to region.

The major companies in this market are Astellas, Lupin Pharmaceuticals, Bristol-Myers Squibb, Glaxo SmithKline, Roche, Ranbaxy, Merck, Pfizer, Sandoz,Teva Pharmaceuticals.

This report offers comprehensive profiles of these companies composed of their business strategy for biosimilars, financials, SWOT analysis, products and services and the insightful company analysis by our analyst.

This Report Offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Cephalosporin Drugs Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global Biosimilars market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Cephalosporins Overview
5.2.1 Chemical Structure
5.2.2 Mechanism of Action
5.2.3 Epidemiology
5.2.4 Adverse Effects
5.2.5 Therapeutic Uses
5.2.6 Dosage
5.3 Porter’s Five Forces
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Consumers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitute Products and Services
5.3.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing R&D Investments
6.1.2 Growing demand for the antibacterials
6.1.3 Increasing Prevalence of Diseases
6.2 Market Restraints
6.2.1 Uncertain regulatory reforms
6.2.2 Low return of investment
6.2.3 Less drugs in pipeline
7. Global Cephalosporin Drugs Market, by Spectrum
7.1 First Generation
7.2 Second Generation
7.3 Third Generation
7.4 Fourth Generation
7.5 Fifth Generation
8. Global Cephalosporin Drugs Market, by Route of Administration
8.1 Oral
8.2 Injectables
9. Global Cephalosporin Drugs Market, by Type
9.1 Branded
9.2 Generics
10. Global Cephalosporin Drugs Market, by Type of Treatment
10.1 First Line of Treatment
10.1.1 Sexually transmitted infections
10.1.1.1 Gonorrhoea
10.1.1.2 Pelvic inflammatory disease
10.1.1.3 Epididymo-orchitis
10.1.2 Serious infections
10.1.2.1 Meningitis
10.2 Second Line of Treatment
10.2.1 Respiratory tract infections
10.2.1.1 Otitis media
10.2.1.2 Sinusitis
10.2.2 Skin infections
10.2.2.1 Cellulitis
10.2.2.2 Diabetic foot infections
10.2.2.3 Mastitis
10.2.3 Urinary tract infections in pregnancy
11. Global Cephalosporin Drugs Market, Regulatory Landscape
12. Global Cephalosporin Drugs Market, by Geography – Regional Share and Forecasts
12.1 North America (NA)
12.1.1 Introduction
12.1.2 United States
12.1.3 Canada
12.1.4 Rest of North America
12.2 Europe
12.2.1 Introduction
12.2.2 Germany
12.2.3 United Kingdom
12.2.4 France
12.2.5 Italy
12.2.6 Spain
12.2.7 Russia
12.2.8 Rest of the Europe
12.3 Asia-Pacific (APAC)
12.3.1 Introduction
12.3.2 China
12.3.3 Japan
12.3.4 India
12.3.5 Australia
12.3.6 South Korea
12.3.7 Rest of Asia-Pacific
12.4 Middle-East and Africa (MEA)
12.4.1 Introduction
12.4.2 UAE
12.4.3 Saudi Arabia
12.6.4 Israel
12.6.5 Rest of the MEA
12.5 Latin America
12.6.1 Introduction
12.6.2 Brazil
12.6.3 Argentina
12.6.4 Mexico
12.6.5 Rest of Latin America
13. Competitive Landscape
13.1 Merger and Acquisition Analysis
13.2 The Challengers
14. Key Vendor Analysis
14.1 Astellas
14.2 Lupin Pharmaceuticals
14.3 Bristol-Myers Squibb
14.4 Glaxo SmithKline
14.5 Roche
14.6 Ranbaxy
14.7 Merck
14.8 Pfizer
14.9 Sandoz
14.10 Teva Pharmaceuticals
15. Analyst Outlook for Investment Opportunities
16. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll